AUG 14, 2026 · PHASE 3 TRIAL
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection
ClinicalTrials.gov
This is a clinical trial registry record describing a planned Phase 3 study with no results yet reported; enrollment is ongoing and primary outcomes have not been assessed.
Reported
Planned sample size400
Primary outcome measureSensitivity and specificity of PET imaging…
Primary outcome timeframe1 year